This website uses cookies for a variety of purposes including to help improve our website, and for other reasons as set out in our privacy policy. By using our website, you acknowledge and consent to the use of essential and analytics cookies, as described in our Cookie Policy. To understand more about how we use cookies or to change your preference and browser settings, please see our Cookie Policy.
Leveraging big data insights in reinsurance
schedule
9 minutes
Pacific Life Re | August 2024
schedule 9 minutes
Watch
Big data analytics has been instrumental for (re)insurers aiming to boost performance, efficiency, and effectiveness. Vasan Errakiah, Managing Director, Protection, Asia, spoke to Asia Insurance Review's deputy editor, Ahmad Zaki, to discuss how Pacific Life Re leverages big data to enhance risk assessment, underwriting and claims management, while also shaping strategic decisions.
This video was first published on Asia Insurance Review.
Discover more Vital Insights
Protection
Leveraging big data insights in reinsurance
Big data analytics has been instrumental for (re)insurers aiming to boost performance, efficiency, and effectiveness.
Medical Advances
Vital Insights Issue 2
From emerging drugs which battle obesity to a review of the effectiveness of new blood tests both to detect cancer and to help slow down Alzheimer’s, we hope these insights help keep you up to date with the latest in medical research.
Medical Advances
Vaping vs. smoking: what are the risks?
Vaping is generally considered less harmful than smoking, however longer-term risks have not had time to emerge and could prove considerable.
Medical Advances
Gut Check: the concerning rise of bowel cancer among young adults
Despite broadly improving cancer mortality, some types of the disease are increasing in incidence
Protection
Serving the Underserved
Consumer Duty has put increased focus on how much value different customers get from financial products. But how well is the protection industry serving different customer groups? Who are the most underserved groups, and what can the industry do to help serve these groups better?
Underwriting & Claims
The future of underwriting is now... are we ready?
Underwriting processes, practices and philosophies are changing with faster pace than we have ever experienced before.
Medical Advances
Tackling the obesity crisis
A new generation of drugs has now well and truly arrived aiming to improve weight loss. The drugs are heavily touted by celebrities and influencers, despite many of them having no medical need to lose weight. Obesity contributes significantly to some of the most common causes of death including heart disease and cancer, as well as affecting quality of life for millions. In this article we look at these increasingly available drugs offering hope to more people with obesity. We consider their potential to broadly improve health, and their limitations.
Medical Advances
New drug may slow down multiple sclerosis
Scientists successfully conducted early-stage trials which provide hope of a future cure for some of the most severe types of multiple sclerosis (MS).
Medical Advances
Exploring the latest medical advances in cancer detection
The world’s largest conference dedicated to the science and treatment of cancer took place in Chicago in early June. The American Society of Clinical Oncology’s annual meeting is a popular forum at which new scientific developments are often revealed.
Medical Advances
Pituitary Neuroendocrine Tumour (PitNET)
A recent review by WHO resulted in reclassification of pituitary adenoma as described in the article
Medical Advances
Climate change and its impact on mortality and morbidity
In 2023 we’ve seen soaring temperatures across the globe along with devastating storms and wildfires. Why is our climate changing and what impact is it having?
Medical Advances
Vital Insights Issue 1
Welcome to our first edition of Vital Insights. Here we’ve put together a collection of articles covering some of the major issues of the day with a specific focus on how they will impact mortality and morbidity.
Medical Advances
Deep dive: Alzheimer's
Total deaths from dementias in high-income countries have almost quadrupled in the last 20 years, yet so far medical science has very few answers. This article looks at the recent emergence of the first drugs which may be able to modify the effects of this terrifying disease
Medical Advances
New Respiratory Syncytial Virus Vaccine
COVID-19 has stolen the limelight from other respiratory viruses in recent years. However there are plenty of other common viruses which can have serious health consequences, among them Respiratory Syncytial Virus, or RSV.
Medical Advances
An end in sight for AIDS
A new UN report reveals optimism about a possible end to the global AIDS epidemic
Medical Advances
Anti-vaccine sentiment increases risk of measles outbreaks
Vaccine technologies have continued to improve greatly in recent years. However, vaccines are little use if people refuse to use them. Here we look at the precarious position of measles, a well-known but little-understood serious condition, which is held in check in most countries only because of high vaccine uptake.
Medical Advances
Does a common sweetener cause cancer
The International Agency for Research on Cancer (IARC), the cancer research arm of the WHO, recently classified the common sweetener aspartame as a possible cause of cancer in humans.
Protection
Building a sustainable protection market
Beneath the Surface report 2023 We explored some of the key drivers of sustainability for the protection market. We undertook consumer research which combined with our medical and underwriting expertise and our deep understanding of the market, enabled us to create this report.
View More add_circle_outline